Citius Oncology Inc banner

Intrinsic Value

Is CTOR undervalued or overvalued?

See the intrinsic value estimate for Citius Oncology Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

CTOR Intrinsic Value
LOCKED
Unlock
Today vs. history

CTOR looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with CTOR’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor CTOR
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price $0.75
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to CTOR

Fundamental Analysis

What Citius Oncology Does

Biotechnology Health Care

Citius Oncology is a biopharmaceutical company focused on developing cancer treatments, especially medicines for people with blood cancers and other oncology needs. Its main job is to take drug candidates through clinical development and try to turn them into approved therapies that doctors can prescribe.

Headquarters
United States of America US
IPO date
Oct 14, 2022
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Citius Oncology Inc

Efficiency

Earnings Waterfall
Citius Oncology Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one CTOR stock?

The intrinsic value for Citius Oncology Inc (CTOR) under the Base Case is hidden USD.

Is CTOR stock undervalued or overvalued?

Compared with the current market price of 0.746 USD, the stock appears hidden.

Back to Top